Sort   by:  
 Page size 
To investigate the effect of the Zn ionophore, PBT2, on the transcriptomic response of Fusobacterium nucleatum ATCC 25586, RNA was extracted from bacterial samples which had been treated as follows: Untreated (0.006% DMSO v/v), DMSO-Zn treated (0.006% DMSO v/v + 200 uM ZnSO4), or PBT2-Zn treated (0....
ORGANISM(S): Fusobacterium nucleatum 
Campylobacter jejuni ATCC 33560 and Campylobacter coli ATCC BAA-1061 were exposed to the antimicrobial ionophore PBT2 to investigate proteome-wide responses associated with its antibacterial activity. Cultures were grown in Mueller-Hinton broth supplemented with 5% defibrinated horse blood and harve...
ORGANISM(S): Campylobacter jejuni subsp. jejuni ATCC 33560 Campylobacter coli RM2228 
2026-06-27 | PXD080115 | Pride
RNAseq transcriptome analysis of K. pneumoniae MS6671 with PBT2 and colistin
RNA-seq of PBT2-Zn treated Fusobacterium nucleatum cells in vitro
The emergence of colistin resistance in carbapenem-resistant and extended-spectrum ß-lactamase (ESBL)-producing bacteria is a significant threat to human health, and new treatment strategies are urgently required. Here we investigated the ability of the safe-for-human use ionophore PBT2 to restore a...
ORGANISM(S): Escherichia coli Klebsiella pneumoniae 
2019-06-13 | GSE132637 | GEO
RNAseq transcriptome analysis of K. pneumoniae MS6671 and E. coli MS8345 treated with PBT2
RNAseq transcriptome analysis of Streptococcus pneumoniae 23F treated with PBT2 and zinc
The emergence of polymyxin resistance in carbapenem-resistant and extended-spectrum -lactamase (ESBL)-producing bacteria is a critical threat to human health, and new treatment strategies are urgently required. Here, we investigated the ability of the safe-for-human use ionophore PBT2 to restore an...
ORGANISM(S): Klebsiella pneumoniae 
2020-07-01 | GSE153553 | GEO
Sort   by:  
 Page size